Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • Conversations with Giants in Medicine
    • Video Abstracts
  • Reviews
    • View all reviews ...
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • Microbiome in Health and Disease (Feb 2025)
    • Substance Use Disorders (Oct 2024)
    • Clonal Hematopoiesis (Oct 2024)
    • Sex Differences in Medicine (Sep 2024)
    • Vascular Malformations (Apr 2024)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • Conversations with Giants in Medicine
  • Video Abstracts
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
Mutations in the iron-sulfur cluster biogenesis protein HSCB cause congenital sideroblastic anemia
Andrew Crispin, … , Mark D. Fleming, Sarah Ducamp
Andrew Crispin, … , Mark D. Fleming, Sarah Ducamp
Published July 7, 2020
Citation Information: J Clin Invest. 2020;130(10):5245-5256. https://doi.org/10.1172/JCI135479.
View: Text | PDF
Research Article Genetics Hematology

Mutations in the iron-sulfur cluster biogenesis protein HSCB cause congenital sideroblastic anemia

  • Text
  • PDF
Abstract

The congenital sideroblastic anemias (CSAs) can be caused by primary defects in mitochondrial iron-sulfur (Fe-S) cluster biogenesis. HSCB (heat shock cognate B), which encodes a mitochondrial cochaperone, also known as HSC20 (heat shock cognate protein 20), is the partner of mitochondrial heat shock protein A9 (HSPA9). Together with glutaredoxin 5 (GLRX5), HSCB and HSPA9 facilitate the transfer of nascent 2-iron, 2-sulfur clusters to recipient mitochondrial proteins. Mutations in both HSPA9 and GLRX5 have previously been associated with CSA. Therefore, we hypothesized that mutations in HSCB could also cause CSA. We screened patients with genetically undefined CSA and identified a frameshift mutation and a rare promoter variant in HSCB in a female patient with non-syndromic CSA. We found that HSCB expression was decreased in patient-derived fibroblasts and K562 erythroleukemia cells engineered to have the patient-specific promoter variant. Furthermore, gene knockdown and deletion experiments performed in K562 cells, zebrafish, and mice demonstrate that loss of HSCB results in impaired Fe-S cluster biogenesis, a defect in RBC hemoglobinization, and the development of siderocytes and more broadly perturbs hematopoiesis in vivo. These results further affirm the involvement of Fe-S cluster biogenesis in erythropoiesis and hematopoiesis and define HSCB as a CSA gene.

Authors

Andrew Crispin, Chaoshe Guo, Caiyong Chen, Dean R. Campagna, Paul J. Schmidt, Daniel Lichtenstein, Chang Cao, Anoop K. Sendamarai, Gordon J. Hildick-Smith, Nicholas C. Huston, Jeanne Boudreaux, Sylvia S. Bottomley, Matthew M. Heeney, Barry H. Paw, Mark D. Fleming, Sarah Ducamp

×

Figure 4

HSCB depletion in zebrafish embryos impairs hemoglobinization.

Options: View larger image (or click on image) Download as PowerPoint
HSCB depletion in zebrafish embryos impairs hemoglobinization.
(A) Whole...
(A) Whole-mount in situ hybridization detects ubiquitous expression of hscb in zebrafish embryos. hscb is weakly expressed in blood islands (arrowheads) at 24 hours postfertilization (hpf). The signal in the ventral tissues is enhanced in the embryos from the dino mutant, which has a ventralized phenotype (29). gata1 is an erythroid transcription factor used to mark the blood islands. (B) hscb morpholino (MO1) induces anemia in zebrafish embryos. Reduced o-dianisidine (heme) staining is observed at both 48 hpf and 72 hpf in the morphant embryos. (C) IRE-independent expression of alas2 rescues the erythroid phenotype in hscb morphant embryos. Tg(globin-LCR:EGFP) transgenic zebrafish embryos were injected with a control morpholino, hscb-MO1 (–), hscb-MO1 + alas2 RNA with the 5′-IRE (+IRE), hscb-MO1 + alas2 RNA without 5′-IRE (–IRE), and hscb-MO1 + alas2 RNA without 5′-IRE but with a premature stop codon (–IREX). The effect of the hscb-MO1 alone and in combination with alas2 RNAs on the numbers of RBCs per embryo was quantified by flow cytometry. All data are normalized to embryos injected with the control morpholino alone. Data are expressed as mean ± SD of 3 independent experiments. ANOVA, ***P < 0.001 vs. hscb-MO1 only.

Copyright © 2025 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts